Company profile
Hi-Great Group Holding Company
OTC: HIGR · Healthcare · Medical - Distribution
#1093 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
25DFH 21DQ 24GM 33SS 38
v0.1 · 65/100 weight · provisional
↑ listing tenure, growth stability · ↓ filing timeliness, balance-sheet leverage
Methodology →Revenue TTM
$41.3k
Rev growth YoY (TTM)
-40.1%
Net income (FY)
-$87.2k
Employees
5
as of 2026-08-24
Market cap
$1.5M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$37.0k$37.0k2025
Net income-$87.2k-$87.2k2025
Operating income-$87.2k-$87.2k2025
Total assets$21.5k$21.5k2025
Liabilities$269.4k$269.4k2025
Equity-$247.9k-$247.9k2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Hi-Great Group Holding Company’s revenue?
Hi-Great Group Holding Company booked $37.0k in FY2025 revenue, contracting 47% year over year — slower than 81% of Healthcare companies we track, at a -236.0% net margin.
Peers · Healthcare
AXIM Biotechnologies, Inc.——AREV Life Sciences Global Corp——Oragenics, Inc.46DGridAI Technologies Corp.30DForte Biosciences, Inc.26DLyell Immunopharma, Inc.31DNeighbors
Los Angeles →Key facts
CEOYang Jun
SectorHealthcare
IndustryMedical - Distribution
HeadquartersLos Angeles, CA
ExchangeOTC: HIGR
Employees5
IPO date2011-05-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.